InnAVasc Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $415K
Latest Deal Amount
  • Investors
  • 8

InnAVasc General Information

Description

Manufacturer of medical devices created to offer vascular access for hemodialysis. The company's devices modify existing synthetic vascular grafts for hemodialysis access, prevent needle cannulation injuries and facilitate graft access safety, enabling physicians to reduce the potential for adverse events and device failures associated with repeated vascular access.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Healthcare Services
Primary Office
  • 110 Swift Avenue
  • Durham, NC 27705
  • United States
+1 (919) 000-0000

InnAVasc Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

InnAVasc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 18-Apr-2020 $415K 00.000 Completed Generating Revenue
6. Debt - General 17-Jul-2019 00000 00.00 Completed Generating Revenue
5. Seed Round 10-Oct-2018 000 00.00 000.00 Completed Generating Revenue
4. Grant 01-Jan-2017 00.000 00.00 Completed Generating Revenue
3. Seed Round 04-Nov-2016 00.000 00.00 00.000 Completed Generating Revenue
2. Debt - General 09-Sep-2016 $250K $250K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view InnAVasc’s complete valuation and funding history, request access »

InnAVasc Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 000,000 00.00 00.00 00 00.00 0.000
Seed 1 0,000,000 00.00 00.00 00 00.00 00.000
To view InnAVasc’s complete cap table history, request access »

InnAVasc Executive Team (5)

Name Title Board Seat Contact Info
Joseph Knight Ph.D President, Chief Executive Officer & Board Member
Shawn Gage Co-Founder, Vice President of Research and Development & Chief Operating Officer
Robert O'Reilly Business Developer
Roberto Manson MD Co-Founder & Vice President, Clinical Operations
Jeffrey Lawson MD Co-Founder & Chairman
To view InnAVasc’s complete executive team members history, request access »

InnAVasc Board Members (9)

Name Representing Role Since
Craig Nichols Self Board Member 000 0000
Greg Davis Self Board Member 000 0000
Jeffrey Lawson MD Self Co-Founder & Chairman 000 0000
Joseph Knight Ph.D InnAVasc President, Chief Executive Officer & Board Member 000 0000
Kenneth Gall Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

InnAVasc Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InnAVasc Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fox Ventures Corporate Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Duke Angel Network Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »